Cargando…

ADSCs and adipocytes are the main producers in the autotaxin–lysophosphatidic acid axis of breast cancer and healthy mammary tissue in vitro

BACKGROUND: Breast cancer is the most common malignancy in women affecting one out of eight females throughout their lives. Autotaxin (ATX) is upregulated in breast cancer which results in increased lysophosphatidic acid (LPA) formation within the tumor. This study’s aim was to identify the role of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schmid, Rafael, Wolf, Katharina, Robering, Jan W., Strauß, Selina, Strissel, Pamela L., Strick, Reiner, Rübner, Matthias, Fasching, Peter A., Horch, Raymund E., Kremer, Andreas E., Boos, Anja M., Weigand, Annika
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6300006/ https://www.ncbi.nlm.nih.gov/pubmed/30567518 http://dx.doi.org/10.1186/s12885-018-5166-z

Ejemplares similares

Influence of the autotaxin-lysophosphatidic acid axis on cellular function and cytokine expression in different breast cancer cell lines
por: Hauck, Theresa, et al.
Publicado: (2022)

Abstract: 11.40 Cell Assisted Lipotransfer -The Interaction Between Adipose Derived Stem Cells And Mammary Epithelial Cells
por: Weigand, Annika, et al.
Publicado: (2017)

Plasticity of patient-matched normal mammary epithelial cells is dependent on autologous adipose-derived stem cells
por: Kengelbach-Weigand, Annika, et al.
Publicado: (2019)

Abstract 73: Selective Isolation And Characterization Of Different Cell Types From Mammary Gland And Carcinoma Tissue For Subsequent Analysis Of Cell-cell Interactions
por: Weigand, Annika, et al.
Publicado: (2017)

An Innovative Arteriovenous (AV) Loop Breast Cancer Model Tailored for Cancer Research
por: An, Ran, et al.
Publicado: (2022)

Mesenchymal stem cells promote lymphangiogenic properties of lymphatic endothelial cells
por: Robering, Jan W., et al.
Publicado: (2018)

Selective isolation and characterization of primary cells from normal breast and tumors reveal plasticity of adipose derived stem cells
por: Weigand, Annika, et al.
Publicado: (2016)

Roles of Autotaxin/Autotaxin-Lysophosphatidic Acid Axis in the Initiation and Progression of Liver Cancer
por: She, Sha, et al.
Publicado: (2022)

Autotaxin–Lysophosphatidic Acid Signaling in Alzheimer’s Disease
por: Ramesh, Sindhu, et al.
Publicado: (2018)

Steroid binding to Autotaxin links bile salts and lysophosphatidic acid signalling
por: Keune, Willem-Jan, et al.
Publicado: (2016)

Autotaxin-Lysophosphatidic Acid: From Inflammation to Cancer Development
por: Valdés-Rives, Silvia Anahi, et al.
Publicado: (2017)

Linking medicinal cannabis to autotaxin–lysophosphatidic acid signaling
por: Eymery, Mathias C, et al.
Publicado: (2023)

Specific features of ex‐obese patients significantly influence the functional cell properties of adipose‐derived stromal cells
por: Schmitz, Deborah, et al.
Publicado: (2022)

Expression of proteins related to autotaxin–lysophosphatidate signaling in thyroid tumors
por: Shin, Eunah, et al.
Publicado: (2019)

MicroRNA Regulation of the Autotaxin-Lysophosphatidic Acid Signaling Axis
por: Murph, Mandi M.
Publicado: (2019)

Lysophosphatidic Acid and Autotaxin-associated Effects on the Initiation and Progression of Colorectal Cancer
por: Yun, C. Chris
Publicado: (2019)

Autotaxin/Lysophosphatidic Acid Axis: From Bone Biology to Bone Disorders
por: Alioli, Candide, et al.
Publicado: (2022)

2-Carba-lysophosphatidic acid is a novel β-lysophosphatidic acid analogue with high potential for lysophosphatidic acid receptor activation and autotaxin inhibition
por: Fukasawa, Keiko, et al.
Publicado: (2021)

L-histidine inhibits production of lysophosphatidic acid by the tumor-associated cytokine, autotaxin
por: Clair, Timothy, et al.
Publicado: (2005)

Recent advances in targeting the autotaxin-lysophosphatidate-lipid phosphate phosphatase axis in vivo
por: Benesch, Matthew G.K., et al.
Publicado: (2016)

Expression of Autotaxin–Lysophosphatidate Signaling-Related Proteins in Breast Cancer with Adipose Stroma
por: Cha, Yoon Jin, et al.
Publicado: (2019)

The autotaxin-lysophosphatidic acid–lysophosphatidic acid receptor cascade: proposal of a novel potential therapeutic target for treating glioblastoma multiforme
por: Tabuchi, Sadaharu
Publicado: (2015)

Autotaxin-Lysophosphatidic Acid Axis Is a Novel Molecular Target for Lowering Intraocular Pressure
por: Iyer, Padma, et al.
Publicado: (2012)

Autotaxin/lysophosphatidic acid signaling mediates obesity‐related cardiomyopathy in mice and human subjects
por: Weng, Jiakan, et al.
Publicado: (2018)

The autotaxin-lysophosphatidic acid pathway emerges as a therapeutic target to prevent liver cancer
por: Erstad, Derek J., et al.
Publicado: (2017)

KAI1/CD82 gene and autotaxin-lysophosphatidic acid axis in gastrointestinal cancers
por: Wang, Shuo, et al.
Publicado: (2022)

Autotaxin–lysophosphatidic acid–LPA (3) signaling at the embryo‐epithelial boundary controls decidualization pathways
por: Aikawa, Shizu, et al.
Publicado: (2017)

Role of Adipose Tissue-Derived Autotaxin, Lysophosphatidate Signaling, and Inflammation in the Progression and Treatment of Breast Cancer
por: Brindley, David N., et al.
Publicado: (2020)

Inhibitors of the Autotaxin-Lysophosphatidic Acid Axis and Their Potential in the Treatment of Interstitial Lung Disease: Current Perspectives
por: Zulfikar, Sabrina, et al.
Publicado: (2020)

Anti-cancer strategies targeting the autotaxin-lysophosphatidic acid receptor axis: is there a path forward?
por: Tigyi, Gábor, et al.
Publicado: (2021)

Disrupted Blood‐Brain Barrier and Mitochondrial Impairment by Autotaxin–Lysophosphatidic Acid Axis in Postischemic Stroke
por: Bhattarai, Susmita, et al.
Publicado: (2021)

Autotaxin Inhibition with IOA-289 Decreases Breast Tumor Growth in Mice Whereas Knockout of Autotaxin in Adipocytes Does Not
por: Tang, Xiaoyun, et al.
Publicado: (2023)

Autotaxin, a synthetic enzyme of lysophosphatidic acid (LPA), mediates the induction of nerve-injured neuropathic pain
por: Inoue, Makoto, et al.
Publicado: (2008)

Autotaxin has lysophospholipase D activity leading to tumor cell growth and motility by lysophosphatidic acid production
por: Umezu-Goto, Makiko, et al.
Publicado: (2002)

Coming of Age for Autotaxin and Lysophosphatidate Signaling: Clinical Applications for Preventing, Detecting and Targeting Tumor-Promoting Inflammation
por: Benesch, Matthew G.K., et al.
Publicado: (2018)

Plasma Concentrations of Lysophosphatidic Acid and Autotaxin in Abstinent Patients with Alcohol Use Disorder and Comorbid Liver Disease
por: Flores-López, María, et al.
Publicado: (2021)

Correction to: Disrupted Blood–Brain Barrier and Mitochondrial Impairment by Autotaxin–Lysophosphatidic Acid Axis in Postischemic Stroke
Publicado: (2023)

Comment on “Microsurgical Techniques Used to Construct the Vascularized and Neurotized Tissue Engineered Bone”
por: Weigand, Annika, et al.
Publicado: (2015)

Increased aqueous autotaxin and lysophosphatidic acid levels are potential prognostic factors after trabeculectomy in different types of glaucoma
por: Igarashi, Nozomi, et al.
Publicado: (2018)

Repeated Fractions of X-Radiation to the Breast Fat Pads of Mice Augment Activation of the Autotaxin-Lysophosphatidate-Inflammatory Cycle
por: Meng, Guanmin, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_qq5j9sm56s2up41mi7dagd4ird